Novavax Inc (NVAX)

Add to Watchlists
Create an Alert
Quickflows
176.00 +3.48  +2.02% NASDAQ May 7, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All NVAX News

News

View All Events

Events

Date Type Description
05/10/2021 00:00 Earnings Results Q1 2021 Earnings Results
05/10/2021 16:30 EDT Earnings Calls Q1 2021 Earnings Call
03/01/2021 00:00 Earnings Results Q4 2020 Earnings Results
03/01/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/09/2020 00:00 Earnings Results Q3 2020 Earnings Results
11/09/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
08/10/2020 16:30 EDT Earnings Calls Q2 2020 Earnings Call
08/10/2020 00:00 Earnings Results Q2 2020 Earnings Results
06/25/2020 08:30 EDT AGM 2019 Annual General Meeting
05/11/2020 16:30 EDT Earnings Calls Q1 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 475.60M
Total Expenses (TTM) 892.32M
Net Income (TTM) -418.26M

Balance Sheet View Statement

Total Assets (Quarterly) 1.582B
Total Liabilities (Quarterly) 955.27M
Shareholders Equity (Quarterly) 627.21M

Cash Flow Statement View Statement

Cash from Operations (TTM) -42.54M
Cash from Investing (TTM) -377.78M
Cash from Financing (TTM) 984.76M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.
  • URL: https://www.novavax.com
  • Investor Relations URL: http://ir.novavax.com/phoenix.zhtml?c=71178&p=irol-irhome
  • HQ State/Province: Maryland
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: May. 10, 2021
  • Last Earnings Release: Mar. 01, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 176.00
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
BBH VanEck Vectors Biotech ETF 3.94%
FIJYX Fidelity Advisor® Biotechnology Z 3.84%
FRBRX Franklin Biotechnology Discovery R6 3.02%
PTH Invesco DWA Healthcare Momentum ETF 1.91%
IBB iShares Nasdaq Biotechnology ETF 1.09%
FCCGX Fidelity Advisor® Small Cap Growth C 1.08%
FSOPX Fidelity® Series Small Cap Opps 1.07%
IWN iShares Russell 2000 Value ETF 0.52%
FSSNX Fidelity® Small Cap Index 0.51%
VTWO Vanguard Russell 2000 ETF 0.40%
SWSSX Schwab Small Cap Index 0.39%
IWM iShares Russell 2000 ETF 0.37%

Comparables

Edit
INO Inovio Pharmaceuticals Inc
REGN Regeneron Pharmaceuticals Inc
MRNA Moderna Inc
GILD Gilead Sciences Inc
JNJ Johnson & Johnson

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.